Dr. Devarakonda is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4921 Parkview Pl
Fl 7
Saint Louis, MO 63110Phone+1 314-747-8479Fax+1 314-362-7086- Is this information wrong?
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2014 - 2017
- St Luke's HospitalResidency, Internal Medicine, 2011 - 2014
- Gandhi Medical CollegeClass of 2009
Certifications & Licensure
- IL State Medical License 2020 - 2026
- WA State Medical License 2022 - 2025
- MO State Medical License 2014 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 178 citationsTumor Mutation Burden as a Biomarker in Resected Non-Small-Cell Lung Cancer.Siddhartha Devarakonda, Federico Rotolo, Ming-Sound Tsao, Irena Lanc, Elisabeth Brambilla
Journal of Clinical Oncology. 2018-08-14 - 232 citationsMYC Drives Temporal Evolution of Small Cell Lung Cancer Subtypes by Reprogramming Neuroendocrine FateAbbie S. Ireland, Alexi M. Micinski, David W. Kastner, Bingqian Guo, Sarah J. Wait
Cancer Cell. 2020-07-13 - 96 citationsRecurrent WNT pathway alterations are frequent in relapsed small cell lung cancerAlex H. Wagner, Siddhartha Devarakonda, Zachary L. Skidmore, Kilannin Krysiak, Avinash Ramu
Nature Communications. 2018-09-17
Journal Articles
- Targeting Resistance to Targeted Therapies: Combating a Resilient FoeSiddhartha Devarakonda, Ramaswamy Govindan, Clinical Cancer Research
Authored Content
- Early Mortality in Patients Undergoing Adjuvant Chemotherapy for Non-Small-Cell Lung CancerFebruary 2018
Press Mentions
- Some Lung Cancer Patients See Big Breakthrough with New DrugJune 11th, 2021
- Friday: New Drug Provides Breakthrough for Some Lung Cancer PatientsJune 10th, 2021
- Biomarkers Advances Continue to Drive Progress in NSCLCMay 3rd, 2017
- Join now to see all
Hospital Affiliations
- Siteman Cancer CenterSaint Louis, Missouri
- Swedish First Hill CampusSeattle, Washington
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: